AZTA Azenta, Inc.
Nasdaq · SEC CIK 933974 · EDGAR
- Bought, last 12 months
- $171.9K 2 purchases by 2 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 206 since 2021-07-23, latest 2026-09-23 10:24
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Cornog William L | Dir | $163.8K | — |
| Starr Ephraim | SVP, Gen Counsel, Sec | $8,096 | — |
| Bello Erik J. | VP CAO | — | — |
| Lin Lawrence Y. | EVP, CFO, Treas | — | — |
| Pirogova Olga | SVP, CHRO | — | — |
| Koffey Quentin | Dir | — | — |
| Zhou Ginger | SVP, GM, Multiomics | — | — |
| MARTIN WILLIAM E. III | Pres Multiomics | — | — |
| Casal Frank | Dir | — | — |
| Marotta John | Pres, CEO, Dir | — | — |
Transactions 211
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-23 10:24 | 2026-09-22 | AZTA | Madaus Martin D | Interim CEO | F - Tax | $34.28 | -1,456 | 42.6K | -3% | -$49.9K | |
| 2026-09-16 21:50 | 2026-09-14 | AZTA | Madaus Martin D | Interim CEO | A - Grant | $0.00 | +36.7K | 44.1K | +495% | $0 | |
| 2026-09-16 20:25 | 2026-09-14 | AZTA | MARTIN WILLIAM E. III | Pres Multiomics | A - Grant | $0.00 | +15.3K | 33.1K | +86% | $0 | |
| 2026-09-16 20:21 | 2026-09-14 | AZTA | Pirogova Olga | SVP, CHRO | A - Grant | $0.00 | +15.3K | 47.2K | +48% | $0 | |
| 2026-09-16 20:19 | 2026-09-14 | AZTA | Lin Lawrence Y. | EVP, CFO, Treas | A - Grant | $0.00 | +30.5K | 110.2K | +38% | $0 | |
| 2026-09-16 20:16 | 2026-09-14 | AZTA | Starr Ephraim | SVP, Gen Counsel, Sec | A - Grant | $0.00 | +15.3K | 84.0K | +22% | $0 | |
| 2026-09-16 20:12 | 2026-09-15 | AZTA | Bello Erik J. | VP CAO | A - Grant | $0.00 | +4,586 | 4,586 | New | $0 | |
| 2026-08-11 16:41 | 2026-08-09 | AZTA | Pirogova Olga | SVP, CHRO | F - Tax | $32.04 | -1,085 | 32.0K | -3% | -$34.8K | |
| 2026-08-04 18:11 | 2026-07-31 | AZTA | Starr Ephraim | SVP, Gen Counsel, Sec | P - Purchase | $24.17 | +335 | 68.7K | +0.5% | +$8,096 | |
| I | 2026-05-19 16:10 | 2026-05-18 | AZTA | Cornog William L | Dir | P - Purchase | $16.38 | +10.0K | 19.7K | +103% | +$163.8K |
| 2026-05-18 16:10 | 2026-05-15 | AZTA | Starr Ephraim | SVP, Gen Counsel, Sec | F - Tax | $16.02 | -3,621 | 68.4K | -5% | -$58.0K | |
| 2026-05-12 16:01 | 2026-02-05 | AZTA | Koffey Quentin | Dir | A - Grant | $0.00 | +5,663 | 10.7K | +112% | $0 | |
| 2026-04-30 16:15 | 2026-04-28 | AZTA | MARTIN WILLIAM E. III | Pres Multiomics | A - Grant | $24.24 | +17.8K | 17.8K | New | +$431.2K | |
| 2026-02-06 | 2026-02-05 | AZTA | Doshi Dipal | Dir | A - Grant | $27.85 | +5,663 | 9,703 | +140% | +$157.7K | |
| 2026-02-06 | 2026-02-05 | AZTA | McLaughlin Erica | Dir | A - Grant | $27.85 | +5,663 | 22.5K | +34% | +$157.7K | |
| 2026-02-06 | 2026-02-06 | AZTA | Nova Tina Susan | Dir | A - Grant | $27.85 | +5,663 | 15.8K | +56% | +$157.7K | |
| 2026-02-06 | 2026-02-05 | AZTA | Casal Frank | Dir | A - Grant | $27.85 | +7,243 | 21.8K | +50% | +$201.7K | |
| A | 2025-12-03 | 2025-11-24 | AZTA | Marotta John | Pres, CEO, Dir | A - Grant | $0.00 | +118.2K | 213.2K | +124% | $0 |
| 2025-11-25 | 2025-11-24 | AZTA | Zhou Ginger | SVP, GM, Multiomics | A - Grant | $0.00 | +13.0K | 38.8K | +51% | $0 | |
| MA | 2025-11-25 | 2025-05-16+ | AZTA | Cornog William L | Dir | P - Purchase | $27.13 | +7,000 | 18.9K | +59% | +$189.9K |
| 2025-11-25 | 2025-11-24 | AZTA | Starr Ephraim | SVP, Gen Counsel, Sec | A - Grant | $0.00 | +34.2K | 72.0K | +91% | $0 | |
| 2025-11-25 | 2025-11-24 | AZTA | Marotta John | Pres, CEO, Dir | A - Grant | $0.00 | +122.3K | 217.3K | +129% | $0 | |
| 2025-11-25 | 2025-11-24 | AZTA | Pirogova Olga | SVP, CHRO | A - Grant | $0.00 | +16.3K | 33.0K | +97% | $0 | |
| 2025-11-25 | 2025-11-24 | AZTA | Lin Lawrence Y. | EVP, CFO, Treas | A - Grant | $0.00 | +36.7K | 79.7K | +85% | $0 | |
| 2025-11-17 | 2025-11-14 | AZTA | Pirogova Olga | SVP, CHRO | F - Tax | $29.75 | -1,553 | 16.7K | -8% | -$46.2K | |
| 2025-11-17 | 2025-11-14 | AZTA | Lin Lawrence Y. | EVP, CFO, Treas | F - Tax | $29.75 | -3,039 | 43.0K | -7% | -$90.4K | |
| 2025-11-17 | 2025-11-14 | AZTA | Zhou Ginger | SVP, GM, Multiomics | F - Tax | $29.75 | -1,118 | 25.7K | -4% | -$33.3K | |
| 2025-11-17 | 2025-11-14 | AZTA | Marotta John | Pres, CEO, Dir | F - Tax | $29.75 | -11.0K | 95.0K | -10% | -$326.7K | |
| A | 2025-11-14 | 2025-08-12 | AZTA | Zhou Ginger | SVP, GM, Multiomics | S - Sale | $28.54 | -1,085 | 26.8K | -4% | -$31.0K |
| A | 2025-11-14 | 2025-05-30 | AZTA | Malus Alan J | Dir | P - Purchase | $26.65 | +12.0K | 17.0K | +238% | +$319.8K |
| A | 2025-11-14 | 2025-06-02 | AZTA | Marotta John | Pres, CEO, Dir | P - Purchase | $25.99 | +1,000 | 107.3K | +0.9% | +$26.0K |
| A | 2025-11-14 | 2025-08-12 | AZTA | Pirogova Olga | SVP, CHRO | S - Sale | $28.54 | -1,085 | 18.3K | -6% | -$31.0K |
| 2025-09-12 | 2025-09-10 | AZTA | Marotta John | Pres, CEO, Dir | S - Sale | $29.41 | -316 | 106.0K | -0.3% | -$9,294 | |
| 2025-08-13 | 2025-08-12 | AZTA | Zhou Ginger | SVP, GM, Multiomics | D - Sale to Iss | $28.54 | -1,085 | 26.8K | -4% | -$31.0K | |
| 2025-08-13 | 2025-08-12 | AZTA | Pirogova Olga | SVP, CHRO | D - Sale to Iss | $28.54 | -1,085 | 18.3K | -6% | -$31.0K | |
| 2025-08-12 | 2025-08-11 | AZTA | Lin Lawrence Y. | EVP, CFO, Treas | P - Purchase | $27.96 | +2,500 | 46.0K | +6% | +$69.9K | |
| MA | 2025-06-04 | 2025-05-08+ | AZTA | Marotta John | Pres, CEO, Dir | A - Grant | $27.49 | +5,434 | 104.5K | +5% | +$149.4K |
| 2025-06-04 | 2025-06-02 | AZTA | Marotta John | Pres, CEO, Dir | A - Grant | $25.99 | +1,000 | 107.3K | +0.9% | +$26.0K | |
| 2025-06-03 | 2025-05-30 | AZTA | Malus Alan J | Dir | A - Grant | $26.65 | +12.0K | 17.0K | +238% | +$319.8K | |
| 2025-05-27 | 2025-05-15 | AZTA | Starr Ephraim | SVP, Gen Counsel, Sec | A - Grant | $26.71 | +37.8K | 37.8K | New | +$1.01M | |
| MI | 2025-05-20 | 2025-05-16+ | AZTA | Cornog William L | Dir | A - Grant | $27.13 | +7,000 | 19.0K | +58% | +$189.9K |
| M | 2025-05-12 | 2025-05-08+ | AZTA | Marotta John | Pres, CEO, Dir | A - Grant | $27.61 | +5,434 | 106.3K | +5% | +$150.0K |
| M | 2025-05-12 | 2025-05-08+ | AZTA | Lin Lawrence Y. | EVP, CFO, Treas | A - Grant | $27.55 | +6,000 | 39.5K | +18% | +$165.3K |
| 2025-02-13 | 2025-02-11 | AZTA | Lin Lawrence Y. | EVP, CFO, Treas | A - Grant | $46.00 | +2,200 | 37.5K | +6% | +$101.2K | |
| 2025-02-11 | 2025-02-07 | AZTA | Malus Alan J | Dir | A - Grant | $52.32 | +4,040 | 5,035 | +406% | +$211.4K | |
| 2025-02-11 | 2025-02-07 | AZTA | Davis Robyn C | Dir | A - Grant | $52.32 | +4,040 | 33.6K | +14% | +$211.4K | |
| 2025-02-11 | 2025-02-07 | AZTA | Casal Frank | Dir | A - Grant | $52.32 | +5,168 | 14.6K | +55% | +$270.4K | |
| 2025-02-11 | 2025-02-07 | AZTA | Koffey Quentin | Dir | A - Grant | $0.00 | +4,040 | 5,035 | +406% | $0 | |
| 2025-02-11 | 2025-02-07 | AZTA | McLaughlin Erica | Dir | A - Grant | $52.32 | +4,040 | 16.9K | +32% | +$211.4K | |
| 2025-02-11 | 2025-02-07 | AZTA | Doshi Dipal | Dir | A - Grant | $52.32 | +4,040 | 4,040 | New | +$211.4K | |
| 2025-02-11 | 2025-02-07 | AZTA | Nova Tina Susan | Dir | A - Grant | $52.32 | +4,040 | 10.1K | +67% | +$211.4K | |
| 2025-02-04 | 2025-02-03 | AZTA | Hughes Violetta | VP, CAO | S - Sale | $52.97 | -317 | 9,603 | -3% | -$16.8K | |
| 2025-02-04 | 2025-01-31 | AZTA | Zhou Ginger | SVP, General Manager, Genom | P - Purchase | $45.88 | +417 | 27.9K | +2% | +$19.1K | |
| M | 2024-12-09 | 2024-12-05 | AZTA | Lin Lawrence Y. | EVP, CFO, Treas | A - Grant | $45.00 | +28.8K | 35.3K | +443% | +$1.30M |
| 2024-12-05 | 2024-12-04 | AZTA | Wang David Dong | SVP, GM, SMS | D - Sale to Iss | $46.65 | -140 | 24.0K | -0.6% | -$6,531 | |
| 2024-11-21 | 2024-11-19 | AZTA | Pirogova Olga | SVP, CHRO | S - Sale | $40.07 | -548 | 19.4K | -3% | -$22.0K | |
| 2024-11-21 | 2024-11-19 | AZTA | Zhou Ginger | SVP, General Manager, Genom | S - Sale | $40.07 | -491 | 27.5K | -2% | -$19.7K | |
| 2024-11-21 | 2024-11-19 | AZTA | Cueto Herman | EVP, CFO | S - Sale | $40.07 | -712 | 23.9K | -3% | -$28.5K | |
| 2024-11-21 | 2024-11-19 | AZTA | Joseph Jason | SVP, GC, Secy | S - Sale | $40.07 | -1,139 | 112.6K | -1% | -$45.6K | |
| 2024-11-21 | 2024-11-19 | AZTA | Wang David Dong | SVP, GM, SMS | S - Sale | $40.07 | -348 | 24.1K | -1% | -$13.9K | |
| 2024-11-21 | 2024-11-19 | AZTA | Hughes Violetta | VP, CAO | S - Sale | $40.07 | -163 | 9,920 | -2% | -$6,531 | |
| I | 2024-11-19 | 2024-11-18 | AZTA | Cornog William L | Dir | P - Purchase | $39.60 | +12.5K | 14.8K | +554% | +$495.0K |
| 2024-11-19 | 2024-11-15 | AZTA | Wang David Dong | SVP, GM, SMS | A - Grant | $41.51 | +8,651 | 24.5K | +55% | +$359.1K | |
| 2024-11-19 | 2024-11-19 | AZTA | Madaus Martin D | Dir | P - Purchase | $40.77 | +4,940 | 7,405 | +200% | +$201.4K | |
| 2024-11-19 | 2024-11-15 | AZTA | Pirogova Olga | SVP, CHRO | A - Grant | $41.51 | +10.4K | 19.9K | +109% | +$430.9K | |
| 2024-11-19 | 2024-11-18 | AZTA | HIRSCH DIDIER | Dir | P - Purchase | $39.50 | +1,000 | 3,465 | +41% | +$39.5K | |
| M | 2024-11-19 | 2024-11-18+ | AZTA | Marotta John | Pres, CEO, Dir | P - Purchase | $39.59 | +14.0K | 99.6K | +16% | +$552.9K |
| 2024-11-19 | 2024-11-15 | AZTA | Marotta John | Pres, CEO, Dir | A - Grant | $41.51 | +83.6K | 86.9K | +2,555% | +$3.47M | |
| 2024-11-19 | 2024-11-15 | AZTA | Zhou Ginger | SVP, General Manager, Genom | A - Grant | $41.51 | +8,651 | 28.0K | +45% | +$359.1K | |
| 2024-11-19 | 2024-11-15 | AZTA | Hughes Violetta | VP, CAO | A - Grant | $41.51 | +6,921 | 10.1K | +219% | +$287.3K | |
| 2024-11-19 | 2024-11-15 | AZTA | Joseph Jason | SVP, GC, Secy | A - Grant | $41.51 | +13.8K | 113.7K | +14% | +$574.5K | |
| 2024-11-14 | 2024-11-06 | AZTA | Malus Alan J | Dir | D - Sale to Iss | $46.52 | +995 | 995 | New | +$46.3K | |
| 2024-11-08 | 2024-11-06 | AZTA | Koffey Quentin | Dir | A - Grant | $0.00 | +995 | 995 | New | $0 | |
| 2024-11-08 | 2024-11-06 | AZTA | Cornog William L | Dir | D - Sale to Iss | $46.52 | -995 | 2,255 | -31% | -$46.3K | |
| 2024-10-21 | 2024-10-17 | AZTA | Cueto Herman | EVP, CFO | S - Sale | $43.68 | -1,595 | 24.6K | -6% | -$69.7K | |
| 2024-09-11 | 2024-09-09 | AZTA | Marotta John | Pres, CEO, Dir | A - Grant | $46.15 | +3,273 | 3,273 | New | +$151.0K | |
| 2024-08-13 | 2024-08-09 | AZTA | Wang David Dong | SVP, GM, SMS | A - Grant | $55.27 | +6,333 | 15.8K | +67% | +$350.0K | |
| 2024-08-13 | 2024-08-09 | AZTA | Pirogova Olga | SVP, CHRO | A - Grant | $55.27 | +6,333 | 9,540 | +197% | +$350.0K | |
| 2024-08-13 | 2024-08-09 | AZTA | Cueto Herman | EVP, CFO | A - Grant | $55.27 | +11.3K | 26.2K | +76% | +$625.0K | |
| 2024-08-13 | 2024-08-09 | AZTA | Joseph Jason | SVP, GC, Secy | A - Grant | $55.27 | +10.9K | 99.9K | +12% | +$600.0K | |
| 2024-08-13 | 2024-08-09 | AZTA | Zhou Ginger | SVP, General Manager, Genom | A - Grant | $55.27 | +6,333 | 19.3K | +49% | +$350.0K | |
| 2024-08-02 | 2024-01-31 | AZTA | Zhou Ginger | SVP, General Manager, Genom | A - Grant | $53.01 | +64 | 13.0K | +0.5% | +$3,393 | |
| 2024-08-02 | 2024-01-31 | AZTA | Vacha Robin | SVP, GM Life Science Products | A - Grant | $53.01 | +151 | 31.4K | +0.5% | +$8,005 | |
| T | 2024-08-01 | 2024-08-01 | AZTA | Joseph Jason | SVP, GC, Secy | D - Sale to Iss | $62.05 | -1,000 | 89.0K | -1% | -$62.0K |
| T | 2024-07-29 | 2024-07-25 | AZTA | Joseph Jason | SVP, GC, Secy | D - Sale to Iss | $60.00 | -3,000 | 90.0K | -3% | -$180.0K |
| 2024-05-22 | 2024-05-20 | AZTA | Hughes Violetta | VP, CAO | D - Sale to Iss | $51.36 | -584 | 3,162 | -16% | -$30.0K | |
| T | 2024-04-02 | 2024-04-01 | AZTA | Joseph Jason | SVP, GC, Secy | D - Sale to Iss | $60.15 | -1,000 | 93.0K | -1% | -$60.1K |
| MT | 2024-03-11 | 2024-03-07+ | AZTA | Joseph Jason | SVP, GC, Secy | D - Sale to Iss | $65.85 | -13.0K | 94.0K | -12% | -$856.0K |
| 2024-02-13 | 2024-02-12 | AZTA | Bousa Edward Peter | Dir | A - Grant | $65.93 | -2,465 | 2,465 | -50% | -$162.5K | |
| 2024-02-13 | 2024-02-12 | AZTA | Rosenblatt Michael | Dir | A - Grant | $65.93 | +2,465 | 13.0K | +23% | +$162.5K | |
| 2024-02-13 | 2024-02-12 | AZTA | Davis Robyn C | Dir | A - Grant | $65.93 | +2,465 | 29.6K | +9% | +$162.5K | |
| 2024-02-13 | 2024-02-12 | AZTA | Madaus Martin D | Dir | A - Grant | $65.93 | +2,465 | 2,465 | New | +$162.5K | |
| 2024-02-13 | 2024-02-12 | AZTA | HIRSCH DIDIER | Dir | A - Grant | $65.93 | +2,465 | 2,465 | New | +$162.5K | |
| 2024-02-13 | 2024-02-12 | AZTA | McLaughlin Erica | Dir | A - Grant | $65.93 | +2,465 | 12.8K | +24% | +$162.5K | |
| 2024-02-13 | 2024-02-12 | AZTA | Nova Tina Susan | Dir | A - Grant | $65.93 | -2,465 | 6,069 | -29% | -$162.5K | |
| 2024-02-13 | 2024-02-12 | AZTA | Casal Frank | Dir | A - Grant | $65.93 | +3,603 | 9,392 | +62% | +$237.5K | |
| 2024-02-02 | 2024-02-01 | AZTA | Vacha Robin | SVP, GM Life Science Products | A - Grant | $39.41 | +324 | 31.3K | +1% | +$12.8K | |
| 2024-02-02 | 2024-02-01 | AZTA | Zhou Ginger | SVP, General Manager, Genom | A - Grant | $39.41 | +448 | 12.9K | +4% | +$17.7K | |
| 2024-02-01 | 2024-01-31 | AZTA | Hughes Violetta | VP, CAO | A - Grant | $65.20 | -311 | 3,746 | -8% | -$20.3K | |
| 2023-12-06 | 2023-12-05 | AZTA | Vacha Robin | SVP, GM Life Science Products | D - Sale to Iss | $56.60 | -5,175 | 25.8K | -17% | -$292.9K |
Purchase Sale Sale after option exercise All abbreviations